Equities

TruBridge Inc

TruBridge Inc

Actions
  • Price (EUR)7.90
  • Today's Change0.00 / 0.00%
  • Shares traded0.00
  • 1 Year change-65.65%
  • Beta--
Data delayed at least 15 minutes, as of May 06 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

TruBridge, Inc. is a provider of healthcare solutions and services for community hospitals, their clinics and other healthcare systems. The Company operates through three segments: RCM, HER and Patient Engagement. The RCM segment focuses on providing a complete revenue cycle management (RCM) solution for all care settings, regardless of their primary healthcare information solutions provider, along with business management, consulting, managed IT services, analytics and business intelligence. The EHR segment provides comprehensive acute care solutions and related services for community hospitals and their physician clinics. The Patient Engagement segment offers comprehensive patient engagement and empowerment technology solutions to improve patient outcomes and engagement strategies with care providers. Its wholly owned subsidiaries include Viewgol, LLC, iNetXperts, Corp. doing business as Get Real Health, Healthcare Resource Group, Inc. and Healthland Holding Inc.

  • Revenue in USD (TTM)339.44m
  • Net income in USD-44.76m
  • Incorporated2002
  • Employees3.22k
  • Location
    TruBridge Inc54 St. Emanuel StreetMOBILE 36602United StatesUSA
  • Phone+1 (251) 639-8100
  • Fax+1 (302) 636-5454
  • Websitehttps://trubridge.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
TBRG:NSQ since
announced
Transaction
value
Viewgol LLCDeal completed16 Oct 202316 Oct 2023Deal completed-43.34%67.50m
Data delayed at least 15 minutes, as of May 07 2024 19:55 BST.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.